This lifetime economic analysis demonstrates vagal nerve blocking therapy to be a cost-effective alternative to conventional therapy in class 2 and 3 obesity patients.
Robert I. Griffiths, ScD, MS
Advertisement
Articles by Robert I. Griffiths, ScD, MS
Advertisement
Latest Updated Articles
- Cost-Effectiveness Analysis of Vagal Nerve Blocking for Morbid Obesity
Published: August 25th 2017 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
In Its 50th Year, ESMO Comes to Berlin, a City Transformed
2
Physical Activity, Vaccination May Protect Against Long COVID
3
Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability
4
CVS Pharmacy Completes Acquisition of Select Rite Aid Locations
5
